Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
08/2010
08/18/2010EP2217565A1 Compounds which modulate the cb2 receptor
08/18/2010EP1940828B1 Heterocyclic aspartyl protease inhibitors
08/18/2010EP1874761B1 4h-1,2,4-triazin-5-one derivatives, their preparation and their use as alpha 7 nicotinic acetylcholine receptors
08/18/2010EP1758857B1 Indole derivatives as antiviral agents
08/18/2010EP1631561B1 Compositions and methods for non-invasive imaging of soluble beta-amyloid
08/18/2010EP1611107B1 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders
08/18/2010EP1578423B1 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
08/18/2010EP1400510B1 Cyclic diamine compounds having fused-ring groups
08/18/2010CN1993352B Piperazine derivatives with CCR3 inhibiting activity
08/18/2010CN101809001A Imidazole derivatives
08/18/2010CN101808638A Antifungal composition
08/18/2010CN101805324A Cyclic carbonate compound and synthesis method thereof
08/18/2010CN101805309A Benzamide derivatives useful as histone deacetylase inhibitors
08/18/2010CN101805281A Oxime ester compound to used for photosensitive polymer composition
08/17/2010US7777055 Photochromic and electrochromic compounds and methods of synthesizing and using same
08/17/2010US7776876 administering cyclic Glycyl-2-Allyl Proline as as neuroprotectants, for the prophylaxis of nervous system disorders
08/17/2010CA2378165C Dihydrobenzodiazepines and their use in the treatment of dyslipidaemia
08/17/2010CA2325471C Piperididinyl and n-amidinopiperidinyl derivatives
08/12/2010WO2010091310A1 Inhibitors of jun n-terminal kinase
08/12/2010WO2010090265A1 Fluorescent solvatochromic pigment
08/12/2010WO2010090200A1 Phenylimidazole compounds
08/12/2010WO2010090077A1 Organic electroluminescent element, and illumination device and display device each comprising the element
08/12/2010WO2010090009A1 Indoline derivatives
08/12/2010WO2010089119A1 Heterocyclic derivatives as m-glu5 antagonists
08/12/2010WO2010089084A1 Substituted indole compounds as bradykinin receptor 1 modulators
08/12/2010US20100204273 Quinoline and Quinazoline Derivatives Having Affinity for 5HT1-Type Receptors
08/12/2010US20100204241 New pyridazin-3(2h)-one derivatives
08/12/2010US20100204236 Substituted imidazoles as bombesin receptor subtype-3 modulators
08/12/2010US20100204219 Aromatic 1,4-di-carboxylamides and their use
08/12/2010US20100204198 Hydrogenated benzo (c) thiophene derivatives as immunomodulators
08/12/2010CA2751536A1 Indoline derivatives
08/12/2010CA2751402A1 Substituted indole compounds as bradykinin receptor 1 modulators
08/12/2010CA2751141A1 Inhibitors of jun n-terminal kinase
08/12/2010CA2750704A1 Phenylimidazole compounds
08/11/2010EP2216334A1 Hiv protease inhibiting sulfonamides
08/11/2010EP2215182A1 New compound and organic light emitting device using the same
08/11/2010EP2215084A2 Therapeutic substituted lactams
08/11/2010EP2215079A1 Inhibitors of c-fms kinase
08/11/2010EP2215074A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
08/11/2010EP2215058A1 Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
08/11/2010EP2214667A2 Small molecule inhibitors of parp activity
08/11/2010EP2214487A1 Novel seh inhibitors and their use
08/11/2010EP2099763B1 2-aminoquinolines as 5-ht(5a) receptor antagonists
08/11/2010CN101801935A uracil or thymine derivative for treating hepatitis c
08/11/2010CN101801934A 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists
08/11/2010CN101801932A Substituted nicotinamide compounds and the use thereof in pharmaceutical products
08/11/2010CN101801371A Process for the preparation of compounds useful as inhibitors of sglt
08/11/2010CN101798282A Multi-substituted fluorine-containing pyridine
08/10/2010US7772407 (1S)-1,5-anhydro-1-[3-(1-benzothien-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity
08/10/2010US7772392 prostaglandin receptor agonists; for treating various ocular hypertensive conditions such as post-surgical and post-laser trabeculectomy ocular hypertensive episodes, glaucoma, and as presurgical adjuncts
08/10/2010US7772270 Octahydrocyclopenta[b]pyrrole-sulfonamide-2-carboxylic acid derivatives; reduced side effects
08/10/2010US7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
08/10/2010US7772241 fused pyrido[3'.2':4.5]pyrrolo[1.2-c]pyrimidine's used for treating cancer in mammals
08/10/2010US7772237 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
08/10/2010US7772230 chroman compound, the method of its preparation and pharmaceutical applications. The compound are represented by formula (I) and its pharmaceutical salt, where in :x is for O or S; n is for 2, 3 or 4; R1 is 6-situ or 7-situ halogen, C1-4alkyl, C1-4alkyoxyl, benzyloxy, acylamino; R2 is nitrogen-containin
08/10/2010CA2451452C Cyclic diamine compound with condensed-ring groups
08/10/2010CA2366800C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/10/2010CA2249542C Pyrazole derivatives, their preparation and their use in pharmaceuticals
08/10/2010CA2237099C Sulfonylaminocarboxylic acids
08/05/2010WO2010087430A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010WO2010085968A1 Toluidine sulfonamides and their use as hif-inhibitors
08/05/2010US20100197942 Novel fluorene compound
08/05/2010US20100197918 2,4-pyrimidinediamine compounds and their uses
08/05/2010US20100197917 Coumarin derivatives useful as tnf alpha inhibitors
08/05/2010US20100197911 Nitrogen-Containing Aromatic Derivatives
08/05/2010US20100197875 White-emitting copolymers, representation, and use thereof
08/05/2010US20100197761 Fused cyclic compounds
08/05/2010US20100197759 Administration of dithiolane compounds for photoprotecting the skin
08/05/2010US20100197754 CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
08/05/2010US20100197736 Cetp activity inhibitors
08/05/2010US20100197727 Quinoline Derivatives as Antibacterial Agents
08/05/2010US20100197688 Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer
08/05/2010US20100197684 Substituted heterocyclic compounds
08/05/2010US20100197667 Biphenyl compounds useful as muscarinic receptor antagonists
08/05/2010US20100196368 Substituted benz-azoles and methods of their use as inhibitors of raf kinase
08/05/2010US20100193774 Quinoid Compounds and Their Use in Semiconducting Matrix Materials, Electronic and Optoelectronic Structural Elements
08/05/2010CA2750452A1 N-acyl anthranilic acid derivative or salt thereof
08/04/2010EP2213167A1 Anthranilamide derivatives and their use for the control of insects and acari
08/04/2010EP2212297A1 Inhibitors of protein kinases
08/04/2010EP2212286A1 Synthesis of quaternary salt compounds
08/04/2010EP2212285A1 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors
08/04/2010EP2212282A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
08/04/2010EP2211615A1 Pyridosulfonamide derivatives as pi3 kinase inhibitors
08/04/2010CN1918141B Aminodibenzodioxin derivative and organic electroluminescent device using same
08/04/2010CN1824662B Substituted pyridine herbicides
08/04/2010CN101796047A luminescent lanthanide (iii) chelates, chelating agents and conjugates derived thereof
08/04/2010CN101796043A Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators
08/04/2010CN101796031A Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions
08/04/2010CN101792436A Benzimidazole derivatives used in the treatment of diseases associated with vanilloid receptor 1
08/04/2010CN101792435A Photochromic thiophene indole combined type asymmetric perfluoro cyclopentene compound as well as synthesizing method and application thereof
08/03/2010US7767815 Fused tricyclic mGluR1 antagonists as therapeutic agents
08/03/2010US7767812 Crystals of pyrimidine compound and process for producing the same
08/03/2010US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/03/2010US7767704 viricides such as N-(3-Chloropropyl)-1-methyl-4-[({[4-(trifluoromethoxy)phenyl]amino}carbonyl)amino]-1H-imidazol-2-carboxamide, used for treating cytomegalovirus infections in humans or animals
08/03/2010US7767695 Substituted piperidines
08/03/2010US7767679 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/03/2010US7767667 Pesticidal heterocycles
08/03/2010CA2598788C Indoline-sulfonamides compounds
08/03/2010CA2526228C Quinoline derivatives as phosphodiesterase inhibitors
08/03/2010CA2459311C 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 523